Judit Anido

Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer

Maurizio Scaltriti, Federico Rojo, Alberto Ocaña et al. · JNCI Journal of the National Cancer Institute · 2007 · 864 citations · Full text

TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma

Judit Anido, Andrea Sáez‐Borderías, Alba Gonzàlez-Juncà et al. · Cancer Cell · 2010 · 569 citations · Full text

Neuro-oncology, Medicine, Cancer Cell Biology +10

TGF-β Increases Glioma-Initiating Cell Self-Renewal through the Induction of LIF in Human Glioblastoma

Silvia Peñuelas, Judit Anido, Rosa M. Prieto-Sánchez et al. · Cancer Cell · 2009 · 522 citations · Full text

Neuro-oncology, Developmental Biology, Medicine +10

Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments.

Joan Albanell, Jordi Codony‐Servat, Federico Rojo et al. · PubMed · 2001 · 275 citations

Epidermal Growth Factor, Extracellular Signal-regulated Kinases, Pathology +19

ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells.

Judit Anido, Pablo Matar, Joan Albanell et al. · PubMed · 2003 · 248 citations